Ryan Maynard
Overview
Ryan Maynard received an average of $2M in total compensation, including $310K in salary, at Cara Therapeutics between 2022 and 2023.
Source: SEC filings on April 22, 2024 and April 20, 2023.
Related executives
We found ten more executives who work or worked at Cara Therapeutics.
Christopher Posner
Cara Therapeutics
Chief Executive Officer
Joana Goncalves
Cara Therapeutics
Chief Medical Officer
Derek Chalmers
Cara Therapeutics
Chief Executive Officer
Frédérique Menzaghi
Cara Therapeutics
Chief Scientific Officer
Scott Terrillion
Cara Therapeutics
General Counsel
Thomas Reilly
Cara Therapeutics
Chief Financial Officer
Mani Mohindru
Cara Therapeutics
Chief Financial Officer
Joseph Stauffer
Cara Therapeutics